Confirmation of TACO1 as a Leigh Syndrome Disease Gene in Two Additional Families

Yavuz Oktay, Serdal Güngör, Lena Zeltner, Sarah Wiethoff, Ludger Schöls, Ece Sonmezler, Elmasnur Yilmaz, Benjamin Munro, Benjamin Bender, Christoph Kernstock, Sofie Kaemereit, Inga Liepelt, Ana Töpf, Uluc Yis, Steven Laurie, Ahmet Yaramis, Stephan Zuchner, Semra Hiz, Hanns Lochmüller, Rebecca SchüleRita Horvath

Research output: Contribution to journalArticle

Abstract

Background: In 2009, we identified TACO1 as a novel mitochondrial disease gene in a single family, however no second family has been described to confirm the role of TACO1 in mitochondrial disease. Objective: In this report, we describe two independent consanguineous families carrying pathogenic variants in TACO1, confirming the phenotype. Methods: Detailed clinical investigations and whole exome sequencing with haplotype analysis have been performed in several members of the two reported families. Results: Clinical phenotype of the patients confirms the originally reported phenotype of a childhood-onset progressive cerebellar and pyramidal syndrome with optic atrophy and learning difficulties. Brain MRI showed periventricular white matter lesions with multiple cystic defects, suggesting leukoencephalopathy in both patients. One patient carried the previously described homozygous TACO1 variant (p.His158ProfsTer8) and haplotype analysis suggested that this variant is a rare founder mutation. The second patient from another family carried a homozygous novel frame shift variant (p.Cys85PhefsTer15). Conclusions: The identification of two Turkish families with similar characteristic clinical presentation and an additional homozygous nonsense mutation confirms that TACO1 is a human mitochondrial disease gene. Although most patients with this clinical presentation undergo next generation sequencing analysis, screening for selected founder mutations in the Turkish population based on the precise clinical presentation may reduce time and cost of finding the genetic diagnosis even in the era of massively parallel sequencing.

Original languageEnglish (US)
Pages (from-to)301-308
Number of pages8
JournalJournal of neuromuscular diseases
Volume7
Issue number3
DOIs
StatePublished - 2020

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Confirmation of TACO1 as a Leigh Syndrome Disease Gene in Two Additional Families'. Together they form a unique fingerprint.

  • Cite this

    Oktay, Y., Güngör, S., Zeltner, L., Wiethoff, S., Schöls, L., Sonmezler, E., Yilmaz, E., Munro, B., Bender, B., Kernstock, C., Kaemereit, S., Liepelt, I., Töpf, A., Yis, U., Laurie, S., Yaramis, A., Zuchner, S., Hiz, S., Lochmüller, H., ... Horvath, R. (2020). Confirmation of TACO1 as a Leigh Syndrome Disease Gene in Two Additional Families. Journal of neuromuscular diseases, 7(3), 301-308. https://doi.org/10.3233/JND-200510